Loading…
Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor
The standard glycine site antagonist of the N-methyl-d-aspartate (NMDA) receptor, 3-phenyl-4-hydroxyquinolin-2(1H)-one (21), was used as a template for bioisostere benzene/thiophene exchange. Phenylacetylation of aminothiophene carboxylic acid methyl esters and subsequent cyclization delivered the t...
Saved in:
Published in: | Journal of medicinal chemistry 2006-02, Vol.49 (3), p.864-871 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43 |
---|---|
cites | cdi_FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43 |
container_end_page | 871 |
container_issue | 3 |
container_start_page | 864 |
container_title | Journal of medicinal chemistry |
container_volume | 49 |
creator | Buchstaller, Hans-Peter Siebert, Carsten D Steinmetz, Ralf Frank, Ina Berger, Michael L Gottschlich, Rudolf Leibrock, Joachim Krug, Michael Steinhilber, Dieter Noe, Christian R |
description | The standard glycine site antagonist of the N-methyl-d-aspartate (NMDA) receptor, 3-phenyl-4-hydroxyquinolin-2(1H)-one (21), was used as a template for bioisostere benzene/thiophene exchange. Phenylacetylation of aminothiophene carboxylic acid methyl esters and subsequent cyclization delivered the three possible thienopyridinone isomers. 4-Hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one (3a), with the shortest distance between the sulfur and the nitrogen atom, was the most potent isomer (K i against the binding of [3H]glycine to rat membranes 16 μM), comparable in potency to the model quinolinone (21, 12 μM). Replacement of the phenyl substituent of 21 by a 2-thienyl residue resulted in a 2−5-fold loss in potency and was abandoned. In the thieno part of the thienopyridinone nucleus, the most successful substituents were halogen (Cl or Br) close to the sulfur atom and short alkyl chains at the other position, resulting in 7h, 8h, 8i, and 8m, with K i values between 5.8 and 10.5 nM. Introduction of a 3‘-phenoxy moiety yielded several compounds with still higher potencies (18h, 18i, 18l, and 18m; K i between 1.1 and 2.0 nM). Quantitative structure−activity relationship (QSAR) calculations resulted in a consistent interpretation of the potencies of most compounds. Several of these 3‘-phenoxy derivatives protected mouse fibroblast cell lines with transfected NMDA receptors from glutamate-induced toxicity. In addition, we report in vivo results for four of these compounds. |
doi_str_mv | 10.1021/jm0503493 |
format | article |
fullrecord | <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_jm0503493</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c506372748</sourcerecordid><originalsourceid>FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43</originalsourceid><addsrcrecordid>eNptkNtuEzEQhi0EoqHlghdAvkGiEi4-7ekyDdC06iGiQUhU1Wp8WOI08a5sV2Lfgwdm00TNDVcjzXzzzehH6B2jJ4xy9nm5phkVshIv0IhlnBJZUvkSjSjlnPCciwP0JsYlpVQwLl6jA5bLjNGMj9Df296nhY0u4rbB84Wzvr3jnwRR97M-OON8623EY52c_40h4kmf2i60yeoEPkUM3mza537hlEttePLcien92arXzlt86rzZ7KYWD4fwNbmyadGviCEQOwgJksUfr6--jI_xd6ttNziO0KsGVtG-3dVD9OPb1_lkSi5vzs4n40sCUhaJlJQaUQnBgXPbiJLlKmsaycsGKgZKgFGZVZyKrFKy0FYJkRtT5mAaK4aWOETHW68ObYzBNnUX3BpCXzNab5Ktn5Md2PdbtntUa2v25C7KAfiwAyBqWDUBvHZxzxWyymWx4ciWczHZP89zCA91Xogiq-ez23r682J6MZuc1r_2XtCxXraPwQ-R_OfBf9oFnDg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)</source><creator>Buchstaller, Hans-Peter ; Siebert, Carsten D ; Steinmetz, Ralf ; Frank, Ina ; Berger, Michael L ; Gottschlich, Rudolf ; Leibrock, Joachim ; Krug, Michael ; Steinhilber, Dieter ; Noe, Christian R</creator><creatorcontrib>Buchstaller, Hans-Peter ; Siebert, Carsten D ; Steinmetz, Ralf ; Frank, Ina ; Berger, Michael L ; Gottschlich, Rudolf ; Leibrock, Joachim ; Krug, Michael ; Steinhilber, Dieter ; Noe, Christian R</creatorcontrib><description>The standard glycine site antagonist of the N-methyl-d-aspartate (NMDA) receptor, 3-phenyl-4-hydroxyquinolin-2(1H)-one (21), was used as a template for bioisostere benzene/thiophene exchange. Phenylacetylation of aminothiophene carboxylic acid methyl esters and subsequent cyclization delivered the three possible thienopyridinone isomers. 4-Hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one (3a), with the shortest distance between the sulfur and the nitrogen atom, was the most potent isomer (K i against the binding of [3H]glycine to rat membranes 16 μM), comparable in potency to the model quinolinone (21, 12 μM). Replacement of the phenyl substituent of 21 by a 2-thienyl residue resulted in a 2−5-fold loss in potency and was abandoned. In the thieno part of the thienopyridinone nucleus, the most successful substituents were halogen (Cl or Br) close to the sulfur atom and short alkyl chains at the other position, resulting in 7h, 8h, 8i, and 8m, with K i values between 5.8 and 10.5 nM. Introduction of a 3‘-phenoxy moiety yielded several compounds with still higher potencies (18h, 18i, 18l, and 18m; K i between 1.1 and 2.0 nM). Quantitative structure−activity relationship (QSAR) calculations resulted in a consistent interpretation of the potencies of most compounds. Several of these 3‘-phenoxy derivatives protected mouse fibroblast cell lines with transfected NMDA receptors from glutamate-induced toxicity. In addition, we report in vivo results for four of these compounds.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm0503493</identifier><identifier>PMID: 16451052</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Animals ; Binding, Competitive ; Biological and medical sciences ; Blood-Brain Barrier - metabolism ; Cell Line ; Cytoprotection ; Electroshock ; Glutamatergic system (aspartate and other excitatory aminoacids) ; Glycine - metabolism ; Glycine - toxicity ; Humans ; In Vitro Techniques ; Male ; Medical sciences ; Mice ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Pharmacology. Drug treatments ; Protein Subunits - antagonists & inhibitors ; Protein Subunits - genetics ; Protein Subunits - metabolism ; Pyridones - chemical synthesis ; Pyridones - chemistry ; Pyridones - pharmacology ; Quantitative Structure-Activity Relationship ; Radioligand Assay ; Rats ; Rats, Wistar ; Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors ; Receptors, N-Methyl-D-Aspartate - genetics ; Receptors, N-Methyl-D-Aspartate - metabolism ; Recombinant Proteins - antagonists & inhibitors ; Recombinant Proteins - genetics ; Recombinant Proteins - metabolism ; Seizures - etiology ; Seizures - prevention & control ; Thiophenes - chemistry ; Transfection</subject><ispartof>Journal of medicinal chemistry, 2006-02, Vol.49 (3), p.864-871</ispartof><rights>Copyright © 2006 American Chemical Society</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43</citedby><cites>FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17496472$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16451052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Buchstaller, Hans-Peter</creatorcontrib><creatorcontrib>Siebert, Carsten D</creatorcontrib><creatorcontrib>Steinmetz, Ralf</creatorcontrib><creatorcontrib>Frank, Ina</creatorcontrib><creatorcontrib>Berger, Michael L</creatorcontrib><creatorcontrib>Gottschlich, Rudolf</creatorcontrib><creatorcontrib>Leibrock, Joachim</creatorcontrib><creatorcontrib>Krug, Michael</creatorcontrib><creatorcontrib>Steinhilber, Dieter</creatorcontrib><creatorcontrib>Noe, Christian R</creatorcontrib><title>Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>The standard glycine site antagonist of the N-methyl-d-aspartate (NMDA) receptor, 3-phenyl-4-hydroxyquinolin-2(1H)-one (21), was used as a template for bioisostere benzene/thiophene exchange. Phenylacetylation of aminothiophene carboxylic acid methyl esters and subsequent cyclization delivered the three possible thienopyridinone isomers. 4-Hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one (3a), with the shortest distance between the sulfur and the nitrogen atom, was the most potent isomer (K i against the binding of [3H]glycine to rat membranes 16 μM), comparable in potency to the model quinolinone (21, 12 μM). Replacement of the phenyl substituent of 21 by a 2-thienyl residue resulted in a 2−5-fold loss in potency and was abandoned. In the thieno part of the thienopyridinone nucleus, the most successful substituents were halogen (Cl or Br) close to the sulfur atom and short alkyl chains at the other position, resulting in 7h, 8h, 8i, and 8m, with K i values between 5.8 and 10.5 nM. Introduction of a 3‘-phenoxy moiety yielded several compounds with still higher potencies (18h, 18i, 18l, and 18m; K i between 1.1 and 2.0 nM). Quantitative structure−activity relationship (QSAR) calculations resulted in a consistent interpretation of the potencies of most compounds. Several of these 3‘-phenoxy derivatives protected mouse fibroblast cell lines with transfected NMDA receptors from glutamate-induced toxicity. In addition, we report in vivo results for four of these compounds.</description><subject>Animals</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Blood-Brain Barrier - metabolism</subject><subject>Cell Line</subject><subject>Cytoprotection</subject><subject>Electroshock</subject><subject>Glutamatergic system (aspartate and other excitatory aminoacids)</subject><subject>Glycine - metabolism</subject><subject>Glycine - toxicity</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Subunits - antagonists & inhibitors</subject><subject>Protein Subunits - genetics</subject><subject>Protein Subunits - metabolism</subject><subject>Pyridones - chemical synthesis</subject><subject>Pyridones - chemistry</subject><subject>Pyridones - pharmacology</subject><subject>Quantitative Structure-Activity Relationship</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors</subject><subject>Receptors, N-Methyl-D-Aspartate - genetics</subject><subject>Receptors, N-Methyl-D-Aspartate - metabolism</subject><subject>Recombinant Proteins - antagonists & inhibitors</subject><subject>Recombinant Proteins - genetics</subject><subject>Recombinant Proteins - metabolism</subject><subject>Seizures - etiology</subject><subject>Seizures - prevention & control</subject><subject>Thiophenes - chemistry</subject><subject>Transfection</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNptkNtuEzEQhi0EoqHlghdAvkGiEi4-7ekyDdC06iGiQUhU1Wp8WOI08a5sV2Lfgwdm00TNDVcjzXzzzehH6B2jJ4xy9nm5phkVshIv0IhlnBJZUvkSjSjlnPCciwP0JsYlpVQwLl6jA5bLjNGMj9Df296nhY0u4rbB84Wzvr3jnwRR97M-OON8623EY52c_40h4kmf2i60yeoEPkUM3mza537hlEttePLcien92arXzlt86rzZ7KYWD4fwNbmyadGviCEQOwgJksUfr6--jI_xd6ttNziO0KsGVtG-3dVD9OPb1_lkSi5vzs4n40sCUhaJlJQaUQnBgXPbiJLlKmsaycsGKgZKgFGZVZyKrFKy0FYJkRtT5mAaK4aWOETHW68ObYzBNnUX3BpCXzNab5Ktn5Md2PdbtntUa2v25C7KAfiwAyBqWDUBvHZxzxWyymWx4ciWczHZP89zCA91Xogiq-ez23r682J6MZuc1r_2XtCxXraPwQ-R_OfBf9oFnDg</recordid><startdate>20060209</startdate><enddate>20060209</enddate><creator>Buchstaller, Hans-Peter</creator><creator>Siebert, Carsten D</creator><creator>Steinmetz, Ralf</creator><creator>Frank, Ina</creator><creator>Berger, Michael L</creator><creator>Gottschlich, Rudolf</creator><creator>Leibrock, Joachim</creator><creator>Krug, Michael</creator><creator>Steinhilber, Dieter</creator><creator>Noe, Christian R</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20060209</creationdate><title>Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor</title><author>Buchstaller, Hans-Peter ; Siebert, Carsten D ; Steinmetz, Ralf ; Frank, Ina ; Berger, Michael L ; Gottschlich, Rudolf ; Leibrock, Joachim ; Krug, Michael ; Steinhilber, Dieter ; Noe, Christian R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Blood-Brain Barrier - metabolism</topic><topic>Cell Line</topic><topic>Cytoprotection</topic><topic>Electroshock</topic><topic>Glutamatergic system (aspartate and other excitatory aminoacids)</topic><topic>Glycine - metabolism</topic><topic>Glycine - toxicity</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Subunits - antagonists & inhibitors</topic><topic>Protein Subunits - genetics</topic><topic>Protein Subunits - metabolism</topic><topic>Pyridones - chemical synthesis</topic><topic>Pyridones - chemistry</topic><topic>Pyridones - pharmacology</topic><topic>Quantitative Structure-Activity Relationship</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors</topic><topic>Receptors, N-Methyl-D-Aspartate - genetics</topic><topic>Receptors, N-Methyl-D-Aspartate - metabolism</topic><topic>Recombinant Proteins - antagonists & inhibitors</topic><topic>Recombinant Proteins - genetics</topic><topic>Recombinant Proteins - metabolism</topic><topic>Seizures - etiology</topic><topic>Seizures - prevention & control</topic><topic>Thiophenes - chemistry</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buchstaller, Hans-Peter</creatorcontrib><creatorcontrib>Siebert, Carsten D</creatorcontrib><creatorcontrib>Steinmetz, Ralf</creatorcontrib><creatorcontrib>Frank, Ina</creatorcontrib><creatorcontrib>Berger, Michael L</creatorcontrib><creatorcontrib>Gottschlich, Rudolf</creatorcontrib><creatorcontrib>Leibrock, Joachim</creatorcontrib><creatorcontrib>Krug, Michael</creatorcontrib><creatorcontrib>Steinhilber, Dieter</creatorcontrib><creatorcontrib>Noe, Christian R</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buchstaller, Hans-Peter</au><au>Siebert, Carsten D</au><au>Steinmetz, Ralf</au><au>Frank, Ina</au><au>Berger, Michael L</au><au>Gottschlich, Rudolf</au><au>Leibrock, Joachim</au><au>Krug, Michael</au><au>Steinhilber, Dieter</au><au>Noe, Christian R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2006-02-09</date><risdate>2006</risdate><volume>49</volume><issue>3</issue><spage>864</spage><epage>871</epage><pages>864-871</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>The standard glycine site antagonist of the N-methyl-d-aspartate (NMDA) receptor, 3-phenyl-4-hydroxyquinolin-2(1H)-one (21), was used as a template for bioisostere benzene/thiophene exchange. Phenylacetylation of aminothiophene carboxylic acid methyl esters and subsequent cyclization delivered the three possible thienopyridinone isomers. 4-Hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one (3a), with the shortest distance between the sulfur and the nitrogen atom, was the most potent isomer (K i against the binding of [3H]glycine to rat membranes 16 μM), comparable in potency to the model quinolinone (21, 12 μM). Replacement of the phenyl substituent of 21 by a 2-thienyl residue resulted in a 2−5-fold loss in potency and was abandoned. In the thieno part of the thienopyridinone nucleus, the most successful substituents were halogen (Cl or Br) close to the sulfur atom and short alkyl chains at the other position, resulting in 7h, 8h, 8i, and 8m, with K i values between 5.8 and 10.5 nM. Introduction of a 3‘-phenoxy moiety yielded several compounds with still higher potencies (18h, 18i, 18l, and 18m; K i between 1.1 and 2.0 nM). Quantitative structure−activity relationship (QSAR) calculations resulted in a consistent interpretation of the potencies of most compounds. Several of these 3‘-phenoxy derivatives protected mouse fibroblast cell lines with transfected NMDA receptors from glutamate-induced toxicity. In addition, we report in vivo results for four of these compounds.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>16451052</pmid><doi>10.1021/jm0503493</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2006-02, Vol.49 (3), p.864-871 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_crossref_primary_10_1021_jm0503493 |
source | American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list) |
subjects | Animals Binding, Competitive Biological and medical sciences Blood-Brain Barrier - metabolism Cell Line Cytoprotection Electroshock Glutamatergic system (aspartate and other excitatory aminoacids) Glycine - metabolism Glycine - toxicity Humans In Vitro Techniques Male Medical sciences Mice Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Pharmacology. Drug treatments Protein Subunits - antagonists & inhibitors Protein Subunits - genetics Protein Subunits - metabolism Pyridones - chemical synthesis Pyridones - chemistry Pyridones - pharmacology Quantitative Structure-Activity Relationship Radioligand Assay Rats Rats, Wistar Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors Receptors, N-Methyl-D-Aspartate - genetics Receptors, N-Methyl-D-Aspartate - metabolism Recombinant Proteins - antagonists & inhibitors Recombinant Proteins - genetics Recombinant Proteins - metabolism Seizures - etiology Seizures - prevention & control Thiophenes - chemistry Transfection |
title | Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T20%3A00%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%20Thieno%5B2,3-b%5DPyridinones%20Acting%20as%20Cytoprotectants%20and%20as%20Inhibitors%20of%20%5B3H%5DGlycine%20Binding%20to%20the%20N-Methyl-d-aspartate%20(NMDA)%20Receptor&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Buchstaller,%20Hans-Peter&rft.date=2006-02-09&rft.volume=49&rft.issue=3&rft.spage=864&rft.epage=871&rft.pages=864-871&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm0503493&rft_dat=%3Cacs_cross%3Ec506372748%3C/acs_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/16451052&rfr_iscdi=true |